{"id": "1335817228172681216", "creation": 1607318620.0, "user_id": "906073061857804289", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "COVAXIN Phase 1 &amp; 2 clinical trials, Bharat Biotech obtained DCGI approval for Phase 3 clinical trials from 26,000 participants in more than 25 centres across India. \n\nThis link will tell you more -https://t.co/WOvLBwp8ki\n\n#covid19 #vaccine #CoronaVaccine #Medtalks #Healthcare", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#CORONAVACCINE", "#MEDTALKS", "#HEALTHCARE"]}